By Ethan Covey
The burden of respiratory syncytial virus (RSV) remains high among U.S. children, and more efforts are needed to address gaps in data regarding RSV prevention strategies, according to a presentation given during the Vaccines and Related Biological Products Advisory Committee meeting, which was held on Dec. 12.
The key to understanding the current epidemiology of RSV is recognizing the outsized impact of the disease, particularly among young Americans.
“CDC estimates that each